Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
Factors stack up to make US issuers and investors eager -
Despite the latest legal development being ostensibly market pleasing, many feel little reason for cheer
-
Banks encouraging investors to lend to cut out competition from other banks
-
Case against power company dismissed but NGOs believe precedent for action has been established
-
◆ Issuer sees sizable orderbook attrition ◆ Trade looks to pay single-digit new issue concessions ◆ Deal flow to dry up from today
-
◆ Mining firm's biggest euro deal since 2020 ◆ Premium appears negligible ◆ Other challenging names could follow
Sub-sections
